PLSE Wins FDA IDE Approval to Launch nPulse AF Ablation Study Trial [Yahoo! Finance]
Pulse Biosciences, Inc (PLSE)
Last pulse biosciences, inc earnings: 11/7 03:42 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.pulsebiosciences.com
Company Research
Source: Yahoo! Finance
Catheter Ablation System study for the treatment of paroxysmal atrial fibrillation. The approval allows PLSE to begin a multicenter clinical trial evaluating its proprietary Nanosecond Pulsed Field Ablation (nsPFA) technology, marking an important regulatory milestone for the cardiac portfolio. For investors, the IDE clearance de-risks the clinical pathway, builds on encouraging European feasibility data and positions PLSE to generate meaningful U.S. clinical evidence that could support broader adoption and future commercialization. Following the announcement, the company's shares closed flat at yesterday's market closing. Shares of the company have lost 4.5% in the year-to-date period compared with the industry's 16.4% growth. The S&P 500 has gained 14.8% in the same time frame. Over the long run, the FDA IDE approval strengthens PLSE's business by advancing its nPulse system toward U.S. commercialization in the fast-growing AF ablation market, while validating its differentiat
Show less
Read more
Impact Snapshot
Event Time:
PLSE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PLSE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PLSE alerts
High impacting Pulse Biosciences, Inc news events
Weekly update
A roundup of the hottest topics
PLSE
News
- Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire
- Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation [Yahoo! Finance]Yahoo! Finance
- Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial FibrillationBusiness Wire
- Pulse Biosciences, Inc. Announces Initiation of Research Collaboration for the Treatment of Benign and Malignant Thyroid Tumors with nPulse™ TechnologyBusiness Wire
- Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire
PLSE
Earnings
- 11/5/25 - Beat
PLSE
Sec Filings
- 12/18/25 - Form 8-K
- 12/12/25 - Form 8-K
- 12/9/25 - Form 8-K
- PLSE's page on the SEC website